ro 43-5054 has been researched along with glycyl-arginyl-glycyl-glutamyl-seryl-proline in 1 studies
| Studies (ro 43-5054) | Trials (ro 43-5054) | Recent Studies (post-2010) (ro 43-5054) | Studies (glycyl-arginyl-glycyl-glutamyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-glutamyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-glutamyl-seryl-proline) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 38 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, N; Hiroyama, T; Katagiri, Y; Suzuki, H; Tanoue, K; Yamazaki, H | 1 |
1 other study(ies) available for ro 43-5054 and glycyl-arginyl-glycyl-glutamyl-seryl-proline
| Article | Year |
|---|---|
Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.
Topics: Antibodies, Monoclonal; Blood Platelets; Cell Line; Clot Retraction; Embryo, Mammalian; Fibrin; Humans; Integrins; Melanoma; Microscopy, Electron; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Receptors, Cytoadhesin; Receptors, Vitronectin; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1995 |